 | • レポートコード：QYR2104Z4575 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、薬剤＆新ドラッグデリバリーシステムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リポソーム、PEG化タンパク質＆ポリペプチド、ポリマーナノ粒子、タンパク質-薬剤複合体、その他）、用途別市場規模（病院＆診療所、がん治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・薬剤＆新ドラッグデリバリーシステムの市場動向 ・企業の競争状況、市場シェア ・薬剤＆新ドラッグデリバリーシステムの種類別市場規模（リポソーム、PEG化タンパク質＆ポリペプチド、ポリマーナノ粒子、タンパク質-薬剤複合体、その他） ・薬剤＆新ドラッグデリバリーシステムの用途別市場規模（病院＆診療所、がん治療センター、その他） ・薬剤＆新ドラッグデリバリーシステムの北米市場規模2016-2027（アメリカ、カナダ） ・薬剤＆新ドラッグデリバリーシステムのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・薬剤＆新ドラッグデリバリーシステムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・薬剤＆新ドラッグデリバリーシステムの中南米市場規模2016-2027（メキシコ、ブラジル） ・薬剤＆新ドラッグデリバリーシステムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Teva、Roche、UCB (Union Chimique Belge)、Celgene、Merck、Gilead Sciences、Sanofi、Pfizer、Takeda、Bausch&Lomb、Samyang Biopharmaceuticals、Johnson & Johnson、TOLMAR、Astellas、AMAG Pharmaceuticals、AbbVie、Dr Reddy、AstraZeneca、Aspen、Acrotech Biopharma、TWi Pharmaceuticals） ・結論 |
Novel drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.
Market Analysis and Insights: Global Pharmaceutics and Novel Drug Delivery Systems Market
The global Pharmaceutics and Novel Drug Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutics and Novel Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutics and Novel Drug Delivery Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutics and Novel Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutics and Novel Drug Delivery Systems market.
Global Pharmaceutics and Novel Drug Delivery Systems Scope and Market Size
Pharmaceutics and Novel Drug Delivery Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutics and Novel Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Other
Segment by Application
Hospitals & Clinic
Cancer Treatment Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
UCB (Union Chimique Belge)
Celgene
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Liposomes
1.2.3 PEGylated Proteins & Polypeptides
1.2.4 Polymer Nanoparticle
1.2.5 Protein–drug Conjugates
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Perspective (2016-2027)
2.2 Pharmaceutics and Novel Drug Delivery Systems Growth Trends by Regions
2.2.1 Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceutics and Novel Drug Delivery Systems Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceutics and Novel Drug Delivery Systems Industry Dynamic
2.3.1 Pharmaceutics and Novel Drug Delivery Systems Market Trends
2.3.2 Pharmaceutics and Novel Drug Delivery Systems Market Drivers
2.3.3 Pharmaceutics and Novel Drug Delivery Systems Market Challenges
2.3.4 Pharmaceutics and Novel Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Revenue
3.1.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Revenue (2016-2021)
3.1.2 Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutics and Novel Drug Delivery Systems Revenue
3.4 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2020
3.5 Pharmaceutics and Novel Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutics and Novel Drug Delivery Systems Breakdown Data by Type
4.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2022-2027)
5 Pharmaceutics and Novel Drug Delivery Systems Breakdown Data by Application
5.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size (2016-2027)
6.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
6.2.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021)
6.2.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027)
6.2.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2027)
6.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
6.3.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021)
6.3.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027)
6.3.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2027)
6.4 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
6.4.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021)
6.4.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size (2016-2027)
7.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
7.2.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2027)
7.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
7.3.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2027)
7.4 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
7.4.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
8.2.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
8.3.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region
8.4.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size (2016-2027)
9.2 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
9.2.1 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2027)
9.3 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
9.3.1 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2027)
9.4 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
9.4.1 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
10.2.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
10.3.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
10.4.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Introduction
11.1.4 Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Introduction
11.2.4 Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Introduction
11.3.4 Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.3.5 Roche Recent Development
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Details
11.4.2 UCB (Union Chimique Belge) Business Overview
11.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Introduction
11.4.4 UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.4.5 UCB (Union Chimique Belge) Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Introduction
11.5.4 Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.5.5 Celgene Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Introduction
11.6.4 Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Introduction
11.7.4 Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.7.5 Gilead Sciences Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Introduction
11.8.4 Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Introduction
11.9.4 Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Introduction
11.10.4 Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.10.5 Takeda Recent Development
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Details
11.11.2 Bausch&Lomb Business Overview
11.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Introduction
11.11.4 Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.11.5 Bausch&Lomb Recent Development
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Details
11.12.2 Samyang Biopharmaceuticals Business Overview
11.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
11.12.4 Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.12.5 Samyang Biopharmaceuticals Recent Development
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Introduction
11.13.4 Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.13.5 Johnson & Johnson Recent Development
11.14 TOLMAR
11.14.1 TOLMAR Company Details
11.14.2 TOLMAR Business Overview
11.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Introduction
11.14.4 TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.14.5 TOLMAR Recent Development
11.15 Astellas
11.15.1 Astellas Company Details
11.15.2 Astellas Business Overview
11.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Introduction
11.15.4 Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.15.5 Astellas Recent Development
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Details
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.16.5 AMAG Pharmaceuticals Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Details
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Introduction
11.17.4 AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.17.5 AbbVie Recent Development
11.18 Dr Reddy
11.18.1 Dr Reddy Company Details
11.18.2 Dr Reddy Business Overview
11.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Introduction
11.18.4 Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.18.5 Dr Reddy Recent Development
11.18 AstraZeneca
.1 AstraZeneca Company Details
.2 AstraZeneca Business Overview
.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Introduction
.4 AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
.5 AstraZeneca Recent Development
11.20 Aspen
11.20.1 Aspen Company Details
11.20.2 Aspen Business Overview
11.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Introduction
11.20.4 Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.20.5 Aspen Recent Development
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Details
11.21.2 Acrotech Biopharma Business Overview
11.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Introduction
11.21.4 Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.21.5 Acrotech Biopharma Recent Development
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Details
11.22.2 TWi Pharmaceuticals Business Overview
11.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
11.22.4 TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
11.22.5 TWi Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Liposomes
Table 3. Key Players of PEGylated Proteins & Polypeptides
Table 4. Key Players of Polymer Nanoparticle
Table 5. Key Players of Protein–drug Conjugates
Table 6. Key Players of Other
Table 7. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2016-2021)
Table 11. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2022-2027)
Table 13. Pharmaceutics and Novel Drug Delivery Systems Market Trends
Table 14. Pharmaceutics and Novel Drug Delivery Systems Market Drivers
Table 15. Pharmaceutics and Novel Drug Delivery Systems Market Challenges
Table 16. Pharmaceutics and Novel Drug Delivery Systems Market Restraints
Table 17. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players (2016-2021)
Table 19. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2020)
Table 20. Ranking of Global Top Pharmaceutics and Novel Drug Delivery Systems Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service
Table 24. Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2016-2021)
Table 28. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Application (2016-2021)
Table 32. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Pharmaceutics and Novel Drug Delivery Systems Product
Table 67. Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 68. Amgen Recent Development
Table 69. Teva Company Details
Table 70. Teva Business Overview
Table 71. Teva Pharmaceutics and Novel Drug Delivery Systems Product
Table 72. Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 73. Teva Recent Development
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche Pharmaceutics and Novel Drug Delivery Systems Product
Table 77. Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 78. Roche Recent Development
Table 79. UCB (Union Chimique Belge) Company Details
Table 80. UCB (Union Chimique Belge) Business Overview
Table 81. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Product
Table 82. UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 83. UCB (Union Chimique Belge) Recent Development
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Pharmaceutics and Novel Drug Delivery Systems Product
Table 87. Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 88. Celgene Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Pharmaceutics and Novel Drug Delivery Systems Product
Table 92. Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 93. Merck Recent Development
Table 94. Gilead Sciences Company Details
Table 95. Gilead Sciences Business Overview
Table 96. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Product
Table 97. Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 98. Gilead Sciences Recent Development
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 102. Sanofi Recent Development
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Pharmaceutics and Novel Drug Delivery Systems Product
Table 106. Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 107. Pfizer Recent Development
Table 108. Takeda Company Details
Table 109. Takeda Business Overview
Table 110. Takeda Pharmaceutics and Novel Drug Delivery Systems Product
Table 111. Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 112. Takeda Recent Development
Table 113. Bausch&Lomb Company Details
Table 114. Bausch&Lomb Business Overview
Table 115. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Product
Table 116. Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 117. Bausch&Lomb Recent Development
Table 118. Samyang Biopharmaceuticals Company Details
Table 119. Samyang Biopharmaceuticals Business Overview
Table 120. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product
Table 121. Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 122. Samyang Biopharmaceuticals Recent Development
Table 123. Johnson & Johnson Company Details
Table 124. Johnson & Johnson Business Overview
Table 125. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Product
Table 126. Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 127. Johnson & Johnson Recent Development
Table 128. TOLMAR Company Details
Table 129. TOLMAR Business Overview
Table 130. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Product
Table 131. TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 132. TOLMAR Recent Development
Table 133. Astellas Company Details
Table 134. Astellas Business Overview
Table 135. Astellas Pharmaceutics and Novel Drug Delivery Systems Product
Table 136. Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 137. Astellas Recent Development
Table 138. AMAG Pharmaceuticals Company Details
Table 139. AMAG Pharmaceuticals Business Overview
Table 140. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product
Table 141. AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 142. AMAG Pharmaceuticals Recent Development
Table 143. AbbVie Company Details
Table 144. AbbVie Business Overview
Table 145. AbbVie Pharmaceutics and Novel Drug Delivery Systems Product
Table 146. AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 147. AbbVie Recent Development
Table 148. Dr Reddy Company Details
Table 149. Dr Reddy Business Overview
Table 150. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Product
Table 151. Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 152. Dr Reddy Recent Development
Table 153. AstraZeneca Company Details
Table 154. AstraZeneca Business Overview
Table 155. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Product
Table 156. AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 157. AstraZeneca Recent Development
Table 158. Aspen Company Details
Table 159. Aspen Business Overview
Table 160. Aspen Pharmaceutics and Novel Drug Delivery Systems Product
Table 161. Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 162. Aspen Recent Development
Table 163. Acrotech Biopharma Company Details
Table 164. Acrotech Biopharma Business Overview
Table 165. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Product
Table 166. Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 167. Acrotech Biopharma Recent Development
Table 168. TWi Pharmaceuticals Company Details
Table 169. TWi Pharmaceuticals Business Overview
Table 170. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product
Table 171. TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 172. TWi Pharmaceuticals Recent Development
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Type: 2020 VS 2027
Figure 2. Liposomes Features
Figure 3. PEGylated Proteins & Polypeptides Features
Figure 4. Polymer Nanoparticle Features
Figure 5. Protein–drug Conjugates Features
Figure 6. Other Features
Figure 7. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2020 VS 2027
Figure 8. Hospitals & Clinic Case Studies
Figure 9. Cancer Treatment Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Pharmaceutics and Novel Drug Delivery Systems Report Years Considered
Figure 12. Global Pharmaceutics and Novel Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Pharmaceutics and Novel Drug Delivery Systems Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions: 2020 VS 2027
Figure 15. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2022-2027)
Figure 16. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players in 2020
Figure 17. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2020
Figure 19. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2016-2021)
Figure 20. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2022-2027)
Figure 21. North America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2016-2027)
Figure 23. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2016-2027)
Figure 24. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2016-2027)
Figure 25. United States Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2016-2027)
Figure 29. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2016-2027)
Figure 30. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2016-2027)
Figure 31. Germany Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Share by Region (2016-2027)
Figure 41. China Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2016-2027)
Figure 49. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2016-2027)
Figure 50. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2016-2027)
Figure 51. Mexico Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2016-2027)
Figure 57. Turkey Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 61. Teva Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 63. UCB (Union Chimique Belge) Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 64. Celgene Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 66. Gilead Sciences Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 69. Takeda Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 70. Bausch&Lomb Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 71. Samyang Biopharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 72. Johnson & Johnson Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 73. TOLMAR Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 74. Astellas Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 75. AMAG Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 76. AbbVie Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 77. Dr Reddy Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 78. AstraZeneca Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 79. Aspen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 80. Acrotech Biopharma Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 81. TWi Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
世界の先進ドラッグデリバリーシステム市場規模・現状・予測（2021年-2027年） Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted de…- 世界の代替ドラッグデリバリーシステム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alternative Drug Delivery Systems Market The global Alternative Drug Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界のドラッグデリバリーポリマー用接着剤溶液市場規模・現状・予測（2021年-2027年） Transdermal drug delivery system are topically administered medicaments in the form of patches that deliver drugs for systemic effects at a predetermined and controlled rate. An adhesive solution for drug delivery polymer, which is a customize solution to fit drug formulation needs using a variety o…
- 世界のドラッグデリバリーシステム（DDS）市場規模・現状・予測（2021年-2027年） Drug Delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect. Market Analysis and Insights: Global Drug Delivery Systems Market The global Drug Delivery Systems market size is projecte…
- 世界の結腸標的化ドラッグデリバリーシステム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colon Targeted Drug Delivery Systems Market The global Colon Targeted Drug Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…